FDA acknowledges CT-related device interference, but reassures patients

Michael Walter | | Radiology Business | Practice Management

The FDA updated its website last week, indicating it has received reports of “adverse effects” related to interference between CT and three types of medical devices: insulin pumps, cardiac implantable electronic devices (such as pacemakers), and neurostimulators.

The update included notes to both patients and healthcare providers.

“Patients: Physicians recommend CT scans for medical reasons,” the update read. “The probability of an adverse event is extremely low.”

The note for providers emphasized that the devices in question should not stop anyone from getting an appropriate CT scan.

“CT irradiation is extremely low, and it is greatly outweighed by the clinical benefit of a medically indicated CT examination,” the update read.

The FDA recommends that patients or providers wishing to report a problem use the MedWatch reporting program.

Michael Walter
Michael Walter, Managing Editor

Michael has more than 18 years of experience as a professional writer and editor. He has written at length about cardiology, radiology, artificial intelligence and other key healthcare topics.

Related Content

US Radiology Specialists affiliate expands into new market
Navigating the radiology workforce shortage: 6 potential solutions
Radiologist rails against insurer’s refusal to cover key interventional service
Blue Cross Blue Shield affiliate rejects MRI contrast coverage, labeling it ‘investigational’
Radiology experts say state Medicaid rates must increase to improve imaging access
Can large language models break language barriers in radiology reports?

Around the web

Health Imaging
Nearly $800,000 settlement offered to family of man who died during MRI exam

The patient, who was being cared for in the ICU, was not accompanied or monitored by nursing staff during his exam, despite being sedated.

Cardiovascular Business
Global shortage of nuclear imaging isotopes may be over

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

Cardiovascular Business
‘A huge win’: CMS significantly increases Medicare payments for cardiac CT

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.